Analysts Viewpoint
UTHR stock rated a Neutral by Goldman
In a filing, United Therapeutics Corp revealed its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.85
Menu
In a filing, United Therapeutics Corp revealed its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.85
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
United Therapeutics Corp’s filing revealed that its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.86 million
United Therapeutics Corp’s recent filing unveils that its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.85
In a filing, United Therapeutics Corp revealed its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.2
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its